FDA Drug recall D-674-2013
Test Cyp 50 mg-estradiol cyp 2 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
- FDA Drug
- Class II
- terminated
- Published 2013-07-10
On 2013-07-10 the FDA classified a Class II recall of Test Cyp 50 mg-estradiol cyp 2 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 by Clinical Specialties Compounding Pharmacy, citing lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-674-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-03-20 |
| Published | 2013-07-10 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Clinical Specialties Compounding Pharmacy |
| Distribution | FL, GA, SC |
Product
Test Cyp 50 mg-estradiol cyp 2 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Identifiers
| code_info | Lot number CABCACBB:31, Exp date: 10/28/2013 and Lot number CABDBGAB:74, Exp date: 1/11/2014. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-674-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.